Hyperfine, Inc.
Key Metrics
- Previous Close
- $0.90
- 52-Week Range
- $0.85 – $2.22
- Market Cap
- $95.88M
- P/E (TTM)
- —
- EPS (TTM)
- -0.37
- Dividend Yield
- —
Advanced Metrics
- Price/Book
- 2.61
- PEG Ratio
- —
- Return on Equity
- -96.97%
- Return on Assets
- -38.82%
- Gross Margin
- 51.41%
- Operating Margin
- -216.93%
- Profit Margin
- -210.75%
- Current Ratio
- 6.15
- Debt/Equity
- 0.36
- Total Debt
- $13.41M
- Free Cash Flow
- $-17.16M
- Revenue Growth
- 44.80%
- Earnings Growth
- —
- Enterprise Value
- $65.59M
Market Snapshot
About
Hyperfine, Inc. is a medical device company that developed the Swoop portable MRI system, designed to bring magnetic resonance imaging capabilities to the point of care. The company's innovative technology aims to make MRI accessible in emergency rooms, intensive care units, and other clinical settings where traditional MRI machines cannot operate. Hyperfine's device is FDA-cleared and represents a significant technological advancement in making diagnostic imaging more portable and affordable. The company targets a market opportunity in expanding MRI access beyond traditional radiology departments. Hyperfine went public through a SPAC merger and continues to pursue commercialization and market adoption of its groundbreaking imaging technology.